Aptevo Therapeutics

Seattle, United States

Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.

May 2026

Post-IPO Equity

Biometrics Biopharma Biotechnology Oncology

Top Investors

Niowave Yorkville Advisors

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Aptevo Therapeutics

Who are Aptevo Therapeutics's investors?

Aptevo Therapeutics's investors include Niowave, Yorkville Advisors.

Where is Aptevo Therapeutics headquartered?

Aptevo Therapeutics is headquartered in Seattle, United States.

What does Aptevo Therapeutics do?

Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.

What stage is Aptevo Therapeutics at?

Aptevo Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 27, 2026.

MLA

"Aptevo Therapeutics — Funding & Investors." VCBacked, May 27, 2026, https://www.vcbacked.co/company/aptevo-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2026). Aptevo Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/aptevo-therapeutics

Wikipedia (cite web)

{{cite web |title=Aptevo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aptevo-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 27, 2026.

Similar Companies in Biometrics